8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 5, 2014 (March 21, 2014)

OxySure Systems, Inc.

(Exact name of registrant as specified in its chapter)

Delaware	000-54137	71-0960725
(State or other jurisdiction of incorporation	(Commission File Number)	(IRS Employer Identification No.)

10880 John W. Elliott Drive, Suite 600, Frisco, TX	75033
(Address of principal executive offices)	(Zip Code)

(972) 294-6450

Registrant's telephone number, including area code

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01 Regulation FD Disclosure.

On March 21, 2014, OxySure Systems, Inc. (“OxySure” or the “Company”) issued a statement announcing the passing of one of its Directors, Mr. Don Reed, who died peacefully at his home in Argyle, Texas on March 5th, 2014. A copy of this statement is attached hereto and is available at the Company's website at www.oxysure.com.

Because of Mr. Reed's unexpected death, the size of the Board of Directors is temporarily reduced from four to three, until a successor is appointed or elected.

The information contained in this Item 7.01 and in Exhibit 99.1 attached to this report is being furnished to the Securities and Exchange Commission and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that Section, or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Statement dated March 21, 2014 regarding the death of Don Reed.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.

Date: March 21, 2014
OXYSURE SYSTEMS, INC.,
a Delaware corporation
By:	/s/ Julian T. Ross
BY:	Julian T. Ross
ITS:	Chief Executive Officer, President,
	Chief Financial Officer, and Secretary

3

EX-99.1

Exhibit 99.1

OxySure Systems is Saddened to Announce the Death of Don Reed, Director

     Frisco, Texas, March 21, 2014 – OxySure Systems, Inc. (“OxySure,” or the “Company”) is saddened to announce the death of Don Reed, a member of the OxySure Board of Directors.  Mr. Reed died peacefully at home in Argyle, Texas on March 5th, 2014. “This is obviously a great loss not only for our Company but for our community,” said Julian Ross, Chairman of the Board. “Don was a stellar business leader and a remarkable human being, and he will be missed by many. Our thoughts and prayers are with Don’s family during this time. We extend our condolences and strongest support to Don’s wife and the rest of his family.”